Delivery Order SPE2DR25D3301-SPE2DR26F18FC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Methylphenidate ER(LA) 20mg capsules (100-count package) with a ceiling value of $4,225.90. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for completion by October 31, 2025. The award leverages AmerisourceBergen's extensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,552.79 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This competitively awarded, firm fixed-price contract is not set-aside and was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count units) with a ceiling value of $2,917.54. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,301.28 for Methylphenidate ER(LA) 10mg capsules (100-count) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, valued at $3,375.52 and scheduled for completion by June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on April 21, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Methylphenidate ER(LA) 30mg capsules in a quantity of 100 units. The contract carries a firm fixed price ceiling value of $1,374.60 and is scheduled for completion by April 22, 2025. This is a competitively awarded, non-set-aside delivery order with no small business...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,358.02 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg, 100-count capsules. The contract is a firm fixed price delivery order with an ultimate completion date of November 19, 2025, and was awarded on November 18, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Methylphenidate ER(LA) 20mg in quantities of 100 capsules, with a ceiling value of $1,175.46 and an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,130.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 30mg capsules (100-count units). This contract award, executed on August 4, 2025, with completion targeted for August 5, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules, with a ceiling value of $5,698.56. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18FCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Methylphenidate ER(LA) 20mg capsules in a quantity of 100 units, with a ceiling value of $1,992.09. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of November 19, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 billion and extending through December 2026. As a prime contractor within the DLA Medical Supply Chain, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical commodities to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company's consistent award of non-set-aside, competitively awarded delivery orders across multiple therapeutic domains demonstrates its established capability to meet federal pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/18/25 |